Adagrasib oral dose of 400 mg twice daily tablets Clinical Trials

1 actively recruiting trial across 1 location

Filter by location:

Anchorage, Alaska1 trial

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

Local Institution - Unk025

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.